Lyell Immunopharma
Venture Capital
Lyell Immunopharma is a Venture Capital firm.
Lyell is a clinical-stage company advancing next-generation CAR T-cell product candidates for patients with cancer.
Biotech
- Website
- lyell.com
- Portfolio Company
- 1
- Recorded investments
- 1
- Latest recorded investment
- Sep 2020
Use investor data through the API.
Example request
curl "https://indexed.vc/api/v1/investors/lyell-immunopharma?depth=slim" -H "X-API-Key: YOUR_API_KEY"Indexed holds 1 portfolio company and 1 funding round for this investor. to use credits for reveals, or explore the API.
Overview
Indexed has recorded 1 investment for Lyell Immunopharma. Its portfolio includes Sonoma Biotherapeutics. Focus areas include Biotech.
Portfolio1
Co-investors8
Sign up to view co-investors
Up to 24 co-investors shown
Venture Capital ×6 · Corporate VC ×2
Recorded investments1
Data from Indexed.vcUpdated
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/lyell-immunopharma"><img src="https://indexed.vc/api/badge/investor/lyell-immunopharma" alt="Lyell Immunopharma on Indexed.vc" width="260" height="76" /></a>